D. Hanson

发表

An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome.

Aleksey A. Porollo, C. de Bruin, V. Mericq, 2015, The Journal of clinical endocrinology and metabolism.

Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data

A. Stevens, D. Hanson, P. Clayton, 2014, The Pharmacogenomics Journal.

Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis

R. Donn, A. Stevens, D. Hanson, 2014, Arthritis Research & Therapy.

Pediatric perspective on pharmacogenomics.

R. Donn, A. Stevens, D. Hanson, 2013, Pharmacogenomics.

Human growth is associated with distinct patterns of gene expression in evolutionarily conserved networks

A. Stevens, D. Hanson, P. Clayton, 2013, BMC Genomics.

Network analysis: a new approach to study endocrine disorders.

R. Donn, A. Stevens, D. Hanson, 2013, Journal of molecular endocrinology.

Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling.

S. Mansour, D. Hanson, P. Clayton, 2012, Journal of molecular endocrinology.

EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age

R. Donn, A. Stevens, D. Hanson, 2014, Blood Cancer Journal.

Pharmacogenomics Related to Growth Disorders

A. Stevens, D. Hanson, P. Clayton, 2013, Hormone Research in Paediatrics.

The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.

P. Scambler, S. Holder, D. Hanson, 2009, American journal of human genetics.

The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor obscurin-like 1

P. Scambler, S. Holder, D. Hanson, 2009 .

Constitutional delay of growth and puberty is not commonly associated with mutations in the acid labile subunit gene.

D. Hanson, P. Clayton, A. Whatmore, 2008, European journal of endocrinology.

Exploring the spectrum of 3‐M syndrome, a primordial short stature disorder of disrupted ubiquitination

D. Hanson, P. Clayton, P. Murray, 2012, Clinical endocrinology.

The Genetics of 3-M Syndrome: Unravelling a Potential New Regulatory Growth Pathway

D. Hanson, P. Clayton, P. Murray, 2011, Hormone Research in Paediatrics.

3-M syndrome: a growth disorder associated with IGF2 silencing

A. Stevens, D. Hanson, P. Clayton, 2013, Endocrine connections.

Identifying biological pathways that underlie primordial short stature using network analysis

A. Stevens, D. Hanson, P. Clayton, 2014, Journal of molecular endocrinology.

Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth.

Dian Donnai, Leslie G Biesecker, Dan Hanson, 2011, American journal of human genetics.

The in vitro functional analysis of single-nucleotide polymorphisms associated with growth hormone (GH) response in children with GH deficiency

A. Stevens, D. Hanson, P. Clayton, 2018, The Pharmacogenomics Journal.

Contents Vol. 80, 2013

P. Czernichow, G. Rappold, H. Wallaschofski, 2014, Hormone Research in Paediatrics.

Metabolites involved in Glycolysis and Amino Acid Metabolism are Altered in Short Children Born Small for Gestational Age

W. Dunn, A. Stevens, D. Hanson, 2016, Pediatric Research.

Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling.

S. Mansour, D. Hanson, S. Nampoothiri, 2012, Journal of Molecular Endocrinology.